← Open Payments lookup

GLORIA RAMOS: Open Payments

NPI 1104374925 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,511 in 138 payments from 15 companies in 2025. Trend: 2023 $1,713 · 2024 $2,580 · 2025 $3,511

Food & beverage: $3,412Education: $99
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$547
Neurocrine BioSciences, Inc.16$448
Vanda Pharmaceuticals Inc.13$426
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$401
ABBVIE INC.18$356
Teva Pharmaceuticals USA, Inc.13$322
E.R. Squibb & Sons, L.L.C.7$278
Alkermes, Inc.12$266
Janssen Pharmaceuticals, Inc5$144
Lundbeck LLC5$135

Products named: REXULTI, INGREZZA, FANAPT, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.